Additionally, they present with hypercalcemia and thromboembolic vascular symptoms due to the high production of parathyroid hormone and stimulation of stanniocalcin-1 signaling mediated by interleukin-6 (IL-6).[9,10]. Here, IL6 is linked to hypercalcemia disease.